Saturday, July 18, 2026

‘Menopause is not a medical condition’: Experts call for better workplace support



Published:

Experts say Canadian workplaces need better menopause support. (Credit: Pexels)

Rhode Island has become the first U.S. state to explicitly require employers to provide reasonable workplace accommodations for employees experiencing menopause. Canadian experts say the move is prompting an important conversation about whether workers in this country need more support, education and legal protections.

The law, which took effect June 24, adds menopause and related medical conditions as protected conditions.

Employers with four or more employees must work with staff to identify reasonable accommodations for menopause symptoms, such as hot flashes and night sweats, unless doing so would create an undue hardship

The legislation also bans employers from denying job opportunities because an employee needs menopause-related accommodations, or forcing workers to take leave if another reasonable accommodation is available.

Employers are also required to update workplace policies and notify employees of their rights under the new law.

‘Menopause is not a medical condition’

While Canada has no comparable legislation specifically addressing menopause in the workplace, experts say the conversation is gaining momentum as more employers recognize the challenges some workers face during the transition.

“Menopause is not a medical condition,” said Dr. Claudio Soares, executive director of the Canadian Menopause Society. “Menopause is a significant time in life that everybody who’s lucky to survive and live long enough will go through. But what we’re talking about is really having access to good quality of care in the workplace during the menopausal years.”

Health Canada describes menopause as a natural stage of life that marks the end of a person’s menstrual cycles. It typically happens between the ages of 45 and 55, when the ovaries no longer consistently produce the reproductive hormones estrogen and progesterone.

Experts say menopause deserves more workplace support. (Credit: Pexels)

The Canadian Centre for Occupational Health and Safety says menopause most often has little or no impact on a person’s ability to do their job. However, it notes some people experience symptoms that can affect their health, attendance and performance at work.

According to the agency, symptoms such as hot flashes, night sweats, sleep disruption, headaches, muscle aches, anxiety and difficulty concentrating can contribute to fatigue, lower energy and reduced productivity in the workplace.

For some workers, those symptoms can make certain jobs especially difficult, said Dr. Alison Shea, a menopause and reproductive mental-health specialist and associate professor at McMaster University.

“If you are working in a high-heat environment or you don’t have access to air conditioning and you’re getting significant hot flashes, this can be very overpowering and really impossible to work in if you’re not getting active treatment for your hot flashes,” she said.

Shea said untreated anxiety, mood changes and irritability can also affect people at work, while urinary urgency or heavier menstrual bleeding during perimenopause may make regular access to washrooms more important.

Menopause may be a normal stage of life, but Shea added that does not mean it cannot have a significant impact on a person’s health, quality of life and ability to perform at work.

Cost of menopause

The impact extends beyond individual workers. A 2023 report from the Menopause Foundation of Canada estimated that unmanaged menopause symptoms cost the Canadian economy about $3.5 billion each year.

The report, which included an economic analysis by Deloitte Canada, estimated menopause contributes to roughly 540,000 lost workdays annually, with employers losing an estimated $237 million in productivity and women losing about $3.3 billion in income through reduced hours, lower pay or leaving the workforce.

The report also found many women struggle to manage menopause at work. About one-third of working women surveyed said their symptoms had negatively affected their job performance, while nearly one-quarter said they hid their symptoms at work.

Experts call for more menopause support in Canadian workplaces. (Credit: Pexels)

Two-thirds said they would not feel comfortable discussing menopause with a supervisor, and nearly half said they would be too embarrassed to ask for workplace support.

Soares said creating workplaces where employees feel comfortable discussing menopause is just as important as any policy change.

“There’s probably a lack of awareness of the medical conditions that could happen,” he said. “Employers could be more aware, create a condition that women can actually express that they’re having those symptoms, and look for support without feeling that they are out of place.”

Support beyond legislation

While Rhode Island’s law requires employers to consider reasonable accommodations for menopause, both Soares and Shea said the bigger challenge in Canada is creating workplaces where employees feel comfortable asking for help.

“This is a time that might require additional support, and we should be feeling that they are empowered to bring this up to the employers,” Soares said, adding that “employers should be supportive and proactive in creating an environment that conversation can happen freely without feeling any kind of discomfort or embarrassment.”

Shea agreed that practical accommodations can make a significant difference, particularly for workers whose symptoms are affecting their daily responsibilities.

“I think being able to talk about it is a huge thing,” she said. “Being able to have an employer who is supportive, having tools in place, perhaps resources that they can turn to for information that they need, and having them understand that it’s OK to talk about it, that it’s a normal stage of life.”

Experts say Canadian workplaces need better menopause support. (Credit: Pexels)

Should Canada follow Rhode Island?

Neither expert said legislation alone is the answer.

Soares said legal protections can help encourage employers to act, but believes education and awareness are ultimately more important in breaking down the stigma surrounding menopause.

“The legal framework isn’t necessarily the one that will break down the barriers in the taboo and the stigma. I believe more in education and awareness,” he said.

Shea said she believes formal workplace protections could be beneficial, but only if they are accompanied by clear medical guidance.

“I think it is potentially a great thing to have,” she said, noting pregnancy accommodations provide one possible model. “If we were to set out specific guidelines, this would be helpful versus having it kind of an all or nothing.”

Shea said many people, including women themselves, underestimate how disruptive menopause symptoms can be until they experience them firsthand.

“I think unless you’ve gone through it or you’re partner to someone who’s going through it, I don’t think that you really understand how bad it can be for some people,” she said.

“The majority of women don’t realize it’s going to be as bad until they get into it themselves ... we need to do more education for everyone, including women themselves, because many women are blindsided.”

 

Inside this massive Indigenous festival where Metis heritage and self-government collide



Published:

A procession of dignitaries walk into the opening ceremonies at Batoche. (Allison Bamford/CTV News)

BATOCHE, Sask. - Amongst a lively celebration of culture, dancing and music, serious talks are taking place about how Saskatchewan’s Metis people will be governed in the future.

Tens of thousands of Metis people from across Canada gather at Batoche, Sask., every summer for one of the country’s largest outdoor Indigenous festivals.

This year, reclaiming Metis identity and self-governance are key topics of conversation.

“It is our inherent right to be self-determining and self-governing,” said Brennan Merasty, minister responsible for self-government and justice with Metis Nation-Saskatchewan.

“That was the vision of our leader and founder, Louis Riel, and that is the path forward,” he said.

Metis Nation-Saskatchewan (MN-S) is in negotiations with the federal government to sign a treaty that would recognize the nation’s right to govern themselves, while granting jurisdiction to manage internal affairs and core governance matters.

The treaty will include further details in key areas such as harmonizing laws and resolving disputes, according to the federal government.

“For over 150 years, we have been struggling in regard to recognition from Canada,” MN-S President Glen McCallum told CTV News.

Both MN-S and the federal government say they are working to foster that relationship.

The two parties have finalized a draft of the treaty that is now being reviewed by Ottawa.

“It takes a while to get to this stage, but we are really happy to be making this step and then the following steps,” said federal Crown-Indigenous Relations Minister Rebecca Alty, who attended the opening ceremonies at Batoche, Sask.

Glen McCallum (left), Rebecca Alty (centre) and Brennan Merasty (right) pose for a photo at Back to Batoche Days. (Allison Bamford/CTV News)

Metis leaders said they were hoping to reach an agreement that would coincide with the Batoche celebrations.

Alty told CTV News there is “no hold up,” rather the government is just following its regular process.

“Sometimes it does not happen (when we want), but we will make it happen,” McCallum said.

“Our people are looking forward to that.”

Once the draft is reviewed, Alty said there is a series of procedural steps that need to take place, including a ratification vote amongst the Metis nation.

The minister could not provide a timeline for when the treaty might be implemented.


SpaceX’s slide risks turning blockbuster IPO into confidence test



Published:


NEW YORK -- SpaceX’s slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings.

Elon Musk’s company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above US$2 trillion.

Since then, trading has been rocky. The stock has slipped below its $150 opening price, but remained above the $135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes.

SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2 per cent at $136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index. The stock dipped as low as $135.52.

A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak.

“It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals,” Maley said.

Investors who bought into the excitement around SpaceX’s listing, “hoping to ‘make a killing’ will be disappointed,” said Greg Halter, director of research at Carnegie Investment Counsel.

He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative.

SpaceX did not immediately respond to a request for comment.

Price discovery not panic?

A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut.

Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion.

“The reality is, (SpaceX) is still undergoing some of this price discovery process,” Lee said.

A fall for SpaceX below $135 would reflect “normal, albeit painful” market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning.

“A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell,” he said

Caution or green light for next IPOs?

Some investors think SpaceX’s stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment.

Carnegie’s Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. “No one wants an IPO to flop or have the initial price be ratcheted down,” Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations.

But Direxion’s Lee said SpaceX’s capital raise could encourage some companies with large funding needs to move faster.

“If I’m OpenAI or if I’m Anthropic and I’m in this true arms race to build the frontier AI model and I need capital, I’m going to try to beat the other one out the door,” Lee said.

Risking retail traders’ skepticism

A drop below the IPO price could hit retail investors, who received about 20 per cent of the allocation, hard.

“Many novice investors have approached SpaceX with a ‘meme stock’ mentality, buying in with capital they cannot afford to lose,” Shahin said, warning that losses could fuel perceptions that markets favor insiders. “The market needs to understand that post-IPO volatility is normal.”

SpaceX’s first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal’s size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments.

“Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price,” said Llerena.

(Reporting by Laura Matthews in New York; Additional reporting by Lewis Krauskopf in New York; Editing by Megan Davies and Rod Nickel)